Uni-Bio Science Group Announces 2024 Interim Results
Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets HONG KONG SAR – …
Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets HONG KONG SAR – …
Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets HONG KONG SAR – EQS Newswire – …